早期插管与COVID-19患者院内死亡率降低相关
该多中心回顾性观察研究在日本66家医院纳入2020年1月至9月期间确诊COVID-19并接受插管的412例患者,其中110例为早期插管(氧流量≤6 L/min时插管)。早期插管组院内死亡率为16.4%(18例),非早期插管组为29.1%(88例),粗OR 0.48(95%CI 0.27-0.84,p=0.009),倾向评分逆概率加权调整后OR 0.28(95%CI 0.19-0.42,p<0.001)。亚组分析显示,早期插管的获益不受年龄和插管时低氧血症严重程度影响,但仅在入院超过2天后插管的患者中与较低院内死亡率相关。作者结论认为,在氧流量≤6 L/min时早期插管与院内死亡率降低相关。
要点
- 早期插管定义为氧流量≤6 L/min时插管,与非早期插管相比院内死亡率更低(18例[16.4%] vs 88例[29.1%])。
- 调整混杂因素后,早期插管与院内死亡率降低独立相关(调整OR 0.28,95%CI 0.19-0.42,p<0.001)。
- 早期插管的获益不受年龄和插管时低氧血症严重程度影响。
- 仅在入院超过2天后插管的患者中,早期插管与较低院内死亡率相关。
- 该研究为多中心回顾性观察研究,结果需结合临床情境解读。
适用人群与场景
- 2020年1月至9月在日本66家医院治疗的COVID-19确诊(逆转录聚合酶链反应阳性)且住院期间接受插管的成人患者。
- 研究纳入中至重度COVID-19患者;排除标准原文未提及。
诊断标准与关键阈值
- 早期插管定义为在氧流量≤6 L/min的条件下进行插管。
- 非早期插管为氧流量>6 L/min时插管。
研究设计与关键结果
- 研究类型:多中心、回顾性、观察性研究,共纳入412例符合条件患者,其中110例接受早期插管。
- 主要终点:早期插管组院内死亡18例(16.4%),非早期插管组死亡88例(29.1%);粗OR 0.48(95%CI 0.27-0.84,p=0.009),倾向评分逆概率加权调整后OR 0.28(95%CI 0.19-0.42,p<0.001)。
- 亚组分析:早期插管的获益不受年龄和插管时低氧血症严重程度影响;但仅在入院超过2天后插管的患者中,早期插管与较低院内死亡率相关。
证据类型、等级与局限
- 证据类型:多中心回顾性观察性研究(非随机对照试验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在氧流量≤6 L/min时早期插管与COVID-19需插管患者院内死亡率降低相关。
- 该研究为回顾性观察设计,早期插管的获益仅在入院超过2天后插管的患者中观察到。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Some academic organizations recommended that physicians intubate patients with COVID-19 with a relatively lower threshold of oxygen usage particularly in the early phase of pandemic. We aimed to elucidate whether early intubation is associated with decreased in-hospital mortality among patients with novel coronavirus disease 2019 (COVID-19) who required intubation.
METHODS: A multicenter, retrospective, observational study was conducted at 66 hospitals in Japan where patients with moderate-to-severe COVID-19 were treated between January and September 2020. Patients who were diagnosed as COVID-19 with a positive reverse-transcription polymerase chain reaction test and intubated during admission were included. Early intubation was defined as intubation conducted in the setting of ≤ 6 L/min of oxygen usage. In-hospital mortality was compared between patients with early and non-early intubation. Inverse probability weighting analyses with propensity scores were performed to adjust patient demographics, comorbidities, hemodynamic status on admission and time at intubation, medications before intubation, severity of COVID-19, and institution characteristics. Subgroup analyses were conducted on the basis of age, severity of hypoxemia at intubation, and days from admission to intubation.
RESULTS: Among 412 patients eligible for the study, 110 underwent early intubation. In-hospital mortality was lower in patients with early intubation than those with non-early intubation (18 [16.4%] vs. 88 [29.1%]; odds ratio, 0.48 [95% confidence interval 0.27-0.84]; p = 0.009, and adjusted odds ratio, 0.28 [95% confidence interval 0.19-0.42]; p < 0.001). The beneficial effects of early intubation were observed regardless of age and severity of hypoxemia at time of intubation; however, early intubation was associated with lower in-hospital mortality only among patients who were intubated later than 2 days after admission.
CONCLUSIONS: Early intubation in the setting of ≤ 6 L/min of oxygen usage was associated with decreased in-hospital mortality among patients with COVID-19 who required intubation. Trial Registration None.
参考来源
- Yamamoto R, Kaito D, Homma K, et al. Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019. Crit Care. 2022. PMID: 35524282. doi:10.1186/s13054-022-03995-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。